CircRFWD3 promotes HNSCC metastasis by modulating miR-27a/b/PPARγ signaling

被引:8
作者
Wei, Zihao [1 ]
Wang, Ying [1 ]
Peng, Jiakuan [1 ]
Li, Honglin [1 ]
Gu, Junjie [1 ]
Ji, Ning [1 ]
Li, Taiwei [1 ]
Zhou, Xikun [2 ,3 ,4 ]
Zeng, Xin [1 ]
Li, Jing [1 ]
Chen, Qianming [1 ]
机构
[1] Sichuan Univ, Natl Clin Res Ctr Oral Dis, West China Hosp Stomatol,State Key Lab Oral Dis, Chinese Acad Med Sci,Res Unit Oral Carcinogenesis, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
[3] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Peoples R China
[4] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China
基金
中国国家自然科学基金;
关键词
PPAR-GAMMA; NECK CANCERS; HEAD; BIOMARKERS;
D O I
10.1038/s41420-022-01066-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in the world, the 5-year survival rate of patients with HNSCC is still about 50% due to frequent metastasis and recurrence. Circular RNAs (circRNAs) have been characterized as key regulators of gene expression in numerous malignancies. However, the role of circRNA in HNSCC metastasis remains largely unknown. Here, we demonstrated that the circRFWD3 was significantly upregulated in HNSCC tissues and cell lines by circRNA microarray analysis and qPCR. Notably, high expression of circRFWD3 is related to highly aggressive HNSCC cell lines and lymph node metastasis in HNSCC patients. After that, Sanger sequencing, RNase R, and actinomycin D assay were performed to verify the ring structure of circRFWD3. Then functional experiments found it could promote the metastasis of HNSCC cells both in vitro and in vivo. Mechanistically, a dual-luciferase reporter assay, FISH, RIP, RNA pull-down, RNA-seq, and western blot experiments were employed and found that circRFWD3 served as a miRNAs sponge for miR-27a/27b, leading to the upregulation of PPAR gamma, and then promoted HNSCC metastasis via NF-kappa B/MMP13 pathway. Finally, ISH and IHC were carried out to determine the expression levels and clinical significances of circRFWD3 and PPAR gamma in clinical cohorts of HNSCC. According to the analysis results from two independent HNSCC cohorts, upregulated expression of circRFWD3 and PPAR gamma were positively associated with worse survival in patients with HNSCC. Overall, our results uncover that circRFWD3 acts a critical role in promoting the aggressiveness of HNSCC cells and is a prognostic marker for the disease, indicating that circRFWD3 may act as a potential therapeutic target in HNSCC.
引用
收藏
页数:14
相关论文
共 38 条
  • [1] Predicting effective microRNA target sites in mammalian mRNAs
    Agarwal, Vikram
    Bell, George W.
    Nam, Jin-Wu
    Bartel, David P.
    [J]. ELIFE, 2015, 4
  • [2] CircRNAs and cancer: Biomarkers and master regulators
    Arnaiz, Esther
    Sole, Carla
    Manterola, Lorea
    Iparraguirre, Leire
    Otaegui, David
    Lawrie, Charles H.
    [J]. SEMINARS IN CANCER BIOLOGY, 2019, 58 : 90 - 99
  • [3] Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review
    Budach, Volker
    Tinhofer, Ingeborg
    [J]. LANCET ONCOLOGY, 2019, 20 (06) : E313 - E326
  • [4] MicroRNA targets in Drosophila
    Anton J Enright
    Bino John
    Ulrike Gaul
    Thomas Tuschl
    Chris Sander
    Debora S Marks
    [J]. Genome Biology, 5 (1)
  • [5] Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
    Ferlay, J.
    Colombet, M.
    Soerjomataram, I.
    Mathers, C.
    Parkin, D. M.
    Pineros, M.
    Znaor, A.
    Bray, F.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (08) : 1941 - 1953
  • [6] circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway
    Gao, Wei
    Guo, Huina
    Niu, Min
    Zheng, Xiwang
    Zhang, Yuliang
    Xue, Xuting
    Bo, Yunfeng
    Guan, Xiaoya
    Li, Zhongxun
    Guo, Yujia
    He, Long
    Zhang, Yu
    Li, Li
    Cao, Jimin
    Wu, Yongyan
    [J]. MOLECULAR CANCER, 2020, 19 (01)
  • [7] Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
    Gatta, Gemma
    Botta, Laura
    Jose Sanchez, Maria
    Anderson, Lesley Ann
    Pierannunzio, Daniela
    Licitra, Lisa
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (15) : 2130 - 2143
  • [8] Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer
    Gonzalez-Avila, Georgina
    Sommer, Bettina
    Mendoza-Posada, Daniel A.
    Ramos, Carlos
    Armando Garcia-Hernandez, A.
    Falfan-Valencia, Ramces
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 137 : 57 - 83
  • [9] RNA in cancer
    Goodall, Gregory J.
    Wickramasinghe, Vihandha O.
    [J]. NATURE REVIEWS CANCER, 2021, 21 (01) : 22 - 36
  • [10] miRBase: tools for microRNA genomics
    Griffiths-Jones, Sam
    Saini, Harpreet Kaur
    van Dongen, Stijn
    Enright, Anton J.
    [J]. NUCLEIC ACIDS RESEARCH, 2008, 36 : D154 - D158